Form 4 Filing for Beta Bionics, Inc.

This filing details transactions made by Christy Jones, a director at Beta Bionics, Inc. On May 21, 2026, Jones sold 1,998 shares of Common Stock at $9.95 per share, pursuant to a Rule 10b5-1 Plan. This transaction resulted in a post-transaction share count of 13,246. Additionally, on the same date, Jones was granted an award of 16,965 restricted stock units under the Issuer's 2025 Equity Incentive Plan. This award had a transaction price of $0.00, and the post-transaction share count increased to 30,211. The filing was signed on May 26, 2026, by Stephen Feider as Attorney-in-Fact.